Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Chester Freeman, residing with continual lymphocytic leukemia, shares the Japanese philosophy of wabi-sabi as a information for sufferers with most cancers. He...
Three main specialists in breast surgical procedure, medical oncology and reconstructive surgical procedure share their insights on the significance of consciousness and...
The U.S. Meals and Drug Administration (FDA) has granted quick monitor designation to the antibody-drug conjugate JSKN003 for the remedy of superior...
For Stephanie Wachtel, receiving a prognosis of triple-positive breast most cancers on the age of 23 was life-changing in various methods.Wachtel, who...
